EDQM Looking for Experts
The directorate is looking for experts to join the European Pharmacopoeia network.
The European Directorate for the Quality of Medicines and Healthcare (EDQM) is opening up its network of pharmaceutical sciences experts to non-European Pharmacopoeia member states and non-observer states in preparation for the publication of the 10th edition of the European Pharmacopoeia (Ph. Eur.). The network, which is made up of more than 700 pharmaceutical experts, contributes their knowledge to the development of the monographs and texts in the Ph. Eur.
The invitation is a result of the increased globalization of the pharmaceutical industry. “This decision is part of a deliberate policy to further involve manufacturers and other stakeholders from outside Europe in the work of the European Pharmacopoeia. Experts from all around the world, whether they are from authorities, industry or academia, will be able to contribute to the preparation of the 10th Edition,” EDQM states in a press release.
Ph. Eur. members interested in becoming a member should submit their candidature to the National Pharmacopoeia Authorities. Candidates from non Ph. Eur. member states should contact the Secretariat.
Source:
EDQM
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
New Cancer Research and Treatment Center in Development in London
May 1st 2025Aviva Capital Partners and developer Socius are investing £1 billion in a 12-acre site to be located at the London Cancer Hub next to The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust’s Sutton site.
